Rare
lephants
Screener
Toggle theme
Amneal Pharmaceuticals, Inc.
AMRX
·
Healthcare, Drug Manufacturers - General
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
107.0%
-5.7%
-3.3%
FY2025
-101.8%
2.9%
2.0%
Download CSV
